BPC 157 and the Difference Between an Evidence Gap and a Cover Up: What the entire human evidence base actually looks like, and the questions to ask next. WellFounded Founders Health & FDA Compliance for Peptide Therapy and BPC 157 Holt Law Frontiers Syzygium aromaticum (clove buds) as a natural antibacterial agent: a promising alternative to combat multidrug resistant bacteria A new FDA advisory panel meeting, influenced by RFK Jr.'s push for broader access, will weigh the potential benefits and risks of widely promoted peptides. Click the link in bio to read FDA Decisions Expected: October 2025 Prime Therapeutics Portal